Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

CXCR2-IN-1

CXCR2-IN-1 is a central nervous system penetrant CXCR2 antagonist with a pIC50 of 9.3.

Product Specifications

CAS Number

[1873376-49-8]

UNSPSC

12352005

Target

CXCR

Type

Reference compound

Related Pathways

GPCR/G Protein; Immunology/Inflammation

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology; Endocrinology

Assay Protocol

https://www.medchemexpress.com/CXCR2-IN-1.html

Purity

99.54

Solubility

DMSO : 5.4 mg/mL (ultrasonic; warming)

Smiles

ClC1=CC=C(NC(NC2=CC=CC(F)=C2Cl)=O)C(O)=C1S(=O)(C3CCN(C)CC3)=O

Molecular Formula

C19H20Cl2FN3O4S

Molecular Weight

476.35

References & Citations

[1]Xu H, et al. Discovery of CNS Penetrant CXCR2 Antagonists for the Potential Treatment of CNS Demyelinating Disorders. ACS Med Chem Lett. 2016 Feb 8;7 (4) :397-402.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Isoform

CXCR2

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

IL8 (Interleukin 8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1) (MaxLight 405) discontinued
247629-ML405 100 µL

IL8 (Interleukin 8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1) (MaxLight 405) discontinued

Ask
View Details
Recombinant Human IL-15 Protein, Untagged, E.coli-500ug
QP1153-500ug 500ug

Recombinant Human IL-15 Protein, Untagged, E.coli-500ug

Ask
View Details
Ibuprofen Impurity 111
RM-I210737-01 10 mg

Ibuprofen Impurity 111

Ask
View Details
Ibuprofen Impurity 111
RM-I210737-02 25 mg

Ibuprofen Impurity 111

Ask
View Details
Ibuprofen Impurity 111
RM-I210737-03 50 mg

Ibuprofen Impurity 111

Ask
View Details
Ibuprofen Impurity 111
RM-I210737-04 100 mg

Ibuprofen Impurity 111

Ask
View Details